According to Silvia Giovannini and colleagues from the Università Cattolica del Sacro Cuore in Rome, Italy, recent ... Researchers led by Chisa Matsumoto conducted a randomized controlled trial to evaluate the incidence of atrial ... More than one drink in patients with type 2 diabetes is associated with increased hypertension, a new study suggests.
... Metformin was associated with a reduction in all-cause mortality, but not a composite study endpoint, in high-risk ... The inhibition of SGLT-2 was not associated with an improvement in left ventricular (LV) reverse remodeling in patients ... Stephen D. Wiviott, MD, talks with DocWire News, about the results and implications from the Dapagliflozin Effect on ... Empagliflozin, an SGLT2 inhibitor, significantly reversed left ventricular (LV) remodeling in a population of diabetic ... A recent study found an association between physical activity (PA) and a decreased risk of type 2 diabetes and ... Albiglutide was superior to placebo for the reduction of major adverse cardiac events (MACE) in patients with type ... Canagliflozin, a sodium glucose cotransporter 2 inhibitor, reduced the risk of cardiovascular (CV) death ... An analysis of a subset of patients from the CANTOS trial suggested that canakinumab does not prevent prediabetes from ...